Condition
HPV-Related Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 10 HPV-Related Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (7), Brazil (1), China (1)). By phase: Phase 2 (6), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 4Countries
Newest HPV-Related Carcinoma clinical trials
All recruiting trials (10)
-
HPV DNA-guided chemoradiation with Retifanlimab for locally advanced anal cancer
This study tests whether adjusting chemoradiation doses based on HPV ctDNA results and adding Retifanlimab after CRT can improve outcomes for adults with new, locally advanced anal cancer.
-
15-valent HPV vaccine for people aged 9–45 in China.
This trial will test whether a 15‑valent HPV vaccine is safe and prompts immune responses in people aged 9–45.
-
Blood ctDNA testing to guide follow-up and treatment for HPV-related cervical and anal canal cancers.
This study will test whether regular blood tests for HPV ctDNA can guide follow-up and whether giving pembrolizumab after radiotherapy helps people with HPV-related cervical or anal canal cancer who still have positive ctDNA.
-
Assessing screening methods for anal intraepithelial neoplasia in HPV patients
This study is testing different screening methods to see which one best finds anal cell changes in people who have survived HPV-related cancers.
-
Using biomarkers to detect early HPV-related throat cancer
This study is testing a new way to use DNA and gene markers to see if they can help find early signs of throat cancer linked to HPV in newly diagnosed patients.
-
Combination treatment for recurrent or metastatic cervical cancer
This study is testing if adding a new treatment called PRGN-2009 to pembrolizumab can help people with recurrent or metastatic cervical cancer who haven't responded to pembrolizumab alone.
-
Immunotherapy using E7 TCR-T cells for HPV-related cancers
This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.
-
E7 T-cell therapy for advanced HPV-related cancers
This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.
-
Using blood tests to determine treatment timing for HPV-related throat cancer
This study is testing if blood tests can help decide when to start treatment for people with HPV-related throat cancer after surgery, by checking their tumor DNA levels.
-
Finding HPV DNA in the blood of people with anal or cervical cancer.
This study will test whether a blood test can find HPV DNA in people with HPV-related anal or cervical cancer before, during, and after radiation treatment.
Related topics
Quick answers
How many HPV-Related Carcinoma clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (7 trials), Brazil (1 trial), China (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.